Answers are grounded in this paper and cite their sources.
Objective: This study aimed to investigate whether an ethanolic extract of Syzygium cumini is able to decrease lipid peroxidation and matrix metalloproteinase (MMP)-2 expression in endothelial cells exposed to plasma from preeclamptic patients. Methods: Endothelial cells were obtained from human umbilical vascular endothelial cells. At confluency, endothelial cells were divided into five groups, which included control (untreated), endothelial cells exposed to 2% plasma from preeclamptic patients (PP), endothelial cells exposed to PP in the presence of ethanolic extract of S.cumini (PP+SC) at the doses of 100, 200 and 400 ppm. Analysis of malondialdehyde (MDA) level as a marker of lipid peroxidation was done colorimetrically. Analysis of MMP-2 level was done by enzyme linked immunosorbent assay (ELISA) technically. Results: This increase in MDA was significantly attenuated by both the 200 and 400 ppm treatments of S.cumini extract. Plasma from PP significantly increased MMP-2 levels compared to untreated cells. This increase in MMP-2 was significantly attenuated by the 200 and 400 ppm doses of the extract. Conclusion: In conclusion, Syzygium cumini extract prohibits the increase in oxidative stress and MMP-2 in endothelial cells induced by plasma from preeclamptic patients. Therefore this may provide a natural therapy for attenuating the maternal endothelial dysfunction found in this disease.
No takes yet. Share an insight, caveat, or question.
Abimulyani et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: